Align isocitrate dehydrogenase (NADP+) (EC 1.1.1.42) (characterized)
to candidate AZOBR_RS10995 AZOBR_RS10995 isocitrate dehydrogenase
Query= BRENDA::B7GQR3 (406 letters) >FitnessBrowser__azobra:AZOBR_RS10995 Length = 407 Score = 602 bits (1551), Expect = e-177 Identities = 288/405 (71%), Positives = 341/405 (84%), Gaps = 1/405 (0%) Query: 1 MAKIKVEGTVVELDGDEMTRVIWKDIKDRLILPYLDVNLDYYDLGIEHRDETDDQVTIDA 60 M KIKV VVELDGDEMTR+IW+ IKD+LILPYLDV+L YYDL +E+RD+TDD+VT+++ Sbjct: 1 MTKIKVANPVVELDGDEMTRIIWQFIKDKLILPYLDVDLKYYDLSVENRDKTDDRVTVES 60 Query: 61 AHAIQKHHVGVKCATITPDEARVKEFGLKKMWKSPNGTIRNILGGTIFREPIVMSNVPRL 120 A+AI+++ VGVKCATITPDEARV EF LKKMWKSPNGTIRNILGGT+FREPIV SNVPR Sbjct: 61 ANAIKQYGVGVKCATITPDEARVTEFNLKKMWKSPNGTIRNILGGTVFREPIVCSNVPRY 120 Query: 121 VPGWTKPIVVARHAFGDQYKATDFKVPGAGQLTVTFTPDDGSEPIQHVVYNYGEDGGVAQ 180 VPGWTKPI++ RHAFGDQYKATDF VPG G+LT+ + P+ G EPI+ VY++ G VA Sbjct: 121 VPGWTKPIIIGRHAFGDQYKATDFVVPGKGKLTIKWVPEGGGEPIEQEVYDFPASG-VAM 179 Query: 181 VQYNVNDSIRGFARACFNYGLMRHYPVYLSTKNTILKAYDGQFKDIFAEVFETEYKDKYA 240 YN+++SI GFA + F YGL R YPVYLSTKNTILKAYDG+FKDIF +VF+ Y ++ Sbjct: 180 GMYNLDESIEGFAHSSFMYGLERGYPVYLSTKNTILKAYDGRFKDIFQKVFDEHYAAQFK 239 Query: 241 EAGLTYEHRLIDDMVASSLKWHGGYIWACKNYDGDVQSDSVAQGFGSLGLMTSVLMTPDG 300 GL YEHRLIDDMVAS+LKW GG++WACKNYDGDVQSD VAQGFGSLGLMTSVL+TPDG Sbjct: 240 AKGLVYEHRLIDDMVASALKWEGGFVWACKNYDGDVQSDIVAQGFGSLGLMTSVLITPDG 299 Query: 301 QTVESEAAHGTVTRHYRRWQKGEKTSTNPIASIFAWTGGLKHRADLDGTPEVRHFAKTLE 360 +TVE+EAAHGTVTRHYR QKG++TSTNPIASI+AWT GL +R D TP+V FA+TLE Sbjct: 300 KTVEAEAAHGTVTRHYREHQKGKETSTNPIASIYAWTQGLAYRGKFDNTPDVVKFAETLE 359 Query: 361 KVIVDTVEGGQMTKDLAMLIGPDEPWLDTDGFMNALDENLAKALA 405 +V V+TVE G MTKDLA+LIGPD+PWL T F++ LDENL K +A Sbjct: 360 RVCVETVESGFMTKDLAILIGPDQPWLTTKQFLDKLDENLQKKMA 404 Lambda K H 0.318 0.136 0.416 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 689 Number of extensions: 23 Number of successful extensions: 2 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 406 Length of database: 407 Length adjustment: 31 Effective length of query: 375 Effective length of database: 376 Effective search space: 141000 Effective search space used: 141000 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.3 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.7 bits) S2: 50 (23.9 bits)
Align candidate AZOBR_RS10995 AZOBR_RS10995 (isocitrate dehydrogenase)
to HMM TIGR00127 (isocitrate dehydrogenase, NADP-dependent (EC 1.1.1.42))
# hmmsearch :: search profile(s) against a sequence database # HMMER 3.3.1 (Jul 2020); http://hmmer.org/ # Copyright (C) 2020 Howard Hughes Medical Institute. # Freely distributed under the BSD open source license. # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - # query HMM file: ../tmp/path.carbon/TIGR00127.hmm # target sequence database: /tmp/gapView.14351.genome.faa # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Query: TIGR00127 [M=409] Accession: TIGR00127 Description: nadp_idh_euk: isocitrate dehydrogenase, NADP-dependent Scores for complete sequences (score includes all domains): --- full sequence --- --- best 1 domain --- -#dom- E-value score bias E-value score bias exp N Sequence Description ------- ------ ----- ------- ------ ----- ---- -- -------- ----------- 3.6e-224 729.7 0.1 4.1e-224 729.5 0.1 1.0 1 lcl|FitnessBrowser__azobra:AZOBR_RS10995 AZOBR_RS10995 isocitrate dehydro Domain annotation for each sequence (and alignments): >> lcl|FitnessBrowser__azobra:AZOBR_RS10995 AZOBR_RS10995 isocitrate dehydrogenase # score bias c-Evalue i-Evalue hmmfrom hmm to alifrom ali to envfrom env to acc --- ------ ----- --------- --------- ------- ------- ------- ------- ------- ------- ---- 1 ! 729.5 0.1 4.1e-224 4.1e-224 1 408 [. 2 404 .. 2 405 .. 0.99 Alignments for each domain: == domain 1 score: 729.5 bits; conditional E-value: 4.1e-224 TIGR00127 1 kkikvanpvveldgdemtriiwelikdklilpyleldlkyydlsvesrdatndkvtkdaaeaikkynva 69 +kikvanpvveldgdemtriiw+ ikdklilpyl++dlkyydlsve+rd+t+d+vt+++a+aik+y+v+ lcl|FitnessBrowser__azobra:AZOBR_RS10995 2 TKIKVANPVVELDGDEMTRIIWQFIKDKLILPYLDVDLKYYDLSVENRDKTDDRVTVESANAIKQYGVG 70 69******************************************************************* PP TIGR00127 70 vkcatitpdearvkefklkkmwkspngtirnilggtvfrepiiikriprlvprwekpiiigrhafgdqy 138 vkcatitpdearv ef+lkkmwkspngtirnilggtvfrepi++ ++pr vp+w+kpiiigrhafgdqy lcl|FitnessBrowser__azobra:AZOBR_RS10995 71 VKCATITPDEARVTEFNLKKMWKSPNGTIRNILGGTVFREPIVCSNVPRYVPGWTKPIIIGRHAFGDQY 139 ********************************************************************* PP TIGR00127 139 katdvvvpgpgklklvykpkdgaekvdlkvydyeeeggvalamyntdesiedfakaslklalekklply 207 katd+vvpg+gkl + ++p++g+e+++ +vyd++ +g va++myn desie+fa++s+ le+++p+y lcl|FitnessBrowser__azobra:AZOBR_RS10995 140 KATDFVVPGKGKLTIKWVPEGGGEPIEQEVYDFPASG-VAMGMYNLDESIEGFAHSSFMYGLERGYPVY 207 **********************************998.******************************* PP TIGR00127 208 lstkntilkkydgrfkdifqevyekqykskfealgiwyehrliddmvaqalkskggyilalknydgdvq 276 lstkntilk ydgrfkdifq+v++++y +f+a+g+ yehrliddmva alk +gg+++a+knydgdvq lcl|FitnessBrowser__azobra:AZOBR_RS10995 208 LSTKNTILKAYDGRFKDIFQKVFDEHYAAQFKAKGLVYEHRLIDDMVASALKWEGGFVWACKNYDGDVQ 276 ********************************************************************* PP TIGR00127 277 sdivaqgfgslglmtsvlvtpdgktveaeaahgtvtrhyrkyqkgeetstnsiasifawsrgllkrakl 345 sdivaqgfgslglmtsvl+tpdgktveaeaahgtvtrhyr++qkg+etstn+iasi+aw++gl+ r+k+ lcl|FitnessBrowser__azobra:AZOBR_RS10995 277 SDIVAQGFGSLGLMTSVLITPDGKTVEAEAAHGTVTRHYREHQKGKETSTNPIASIYAWTQGLAYRGKF 345 ********************************************************************* PP TIGR00127 346 dntaelvkfaeilesatietveegimtkdlalilkksklersayltteefldaveerlkkkle 408 dnt+++vkfae+le +++etve+g+mtkdla++++ + +ltt++fld+++e+l+kk++ lcl|FitnessBrowser__azobra:AZOBR_RS10995 346 DNTPDVVKFAETLERVCVETVESGFMTKDLAILIGPD----QPWLTTKQFLDKLDENLQKKMA 404 **********************************999....89*****************997 PP Internal pipeline statistics summary: ------------------------------------- Query model(s): 1 (409 nodes) Target sequences: 1 (407 residues searched) Passed MSV filter: 1 (1); expected 0.0 (0.02) Passed bias filter: 1 (1); expected 0.0 (0.02) Passed Vit filter: 1 (1); expected 0.0 (0.001) Passed Fwd filter: 1 (1); expected 0.0 (1e-05) Initial search space (Z): 1 [actual number of targets] Domain search space (domZ): 1 [number of targets reported over threshold] # CPU time: 0.01u 0.00s 00:00:00.01 Elapsed: 00:00:00.01 # Mc/sec: 11.77 // [ok]
This GapMind analysis is from Sep 17 2021. The underlying query database was built on Sep 17 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see the paper from 2019 on GapMind for amino acid biosynthesis, the paper from 2022 on GapMind for carbon sources, or view the source code.
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory